The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Reassurance for women living with HIV as commonly prescribed HIV drug deemed as safe as other regimes.
New research highlights significant gaps in health outcomes for adolescents born with HIV across the world – but paints a hopeful picture for the future as treatment access expands.
Interim clinical trial results offer hope to people living with hepatitis C who stand to benefit from reduced price treatment, including the 2.3 million people who have HIV co-infection.
Adolescent girls have an important role to play in influencing adolescent boys’ decision to undergo voluntary medical male circumcision (VMMC), new research suggests.
Researchers recommend dolutegravir (DTG)‐based antiretrovirals should become the first option for HIV treatment in India, following a study into DTG’s cost-effectiveness.
Findings show that fear of prosecution can drive new infections, as it puts men off knowing their status.
Adolescent treatment non-adherence remains a major challenge in sub-Saharan Africa. Addressing structural barriers to care retention, such as violence, could be key.
